SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026)

SELLAS Life Sciences (SLS) reported Treasury Shares of $3.8 million for Q3 2017, little changed year-over-year from $3.8 million in Q3 2016, and little changed quarter-over-quarter from $3.8 million in Q2 2017.

SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026) Analysis & Trends

SELLAS Life Sciences (SLS) has 8 years of Treasury Shares data on file, last reported at $3.8 million in Q3 2017.

  • Treasury Shares for Q3 2017 came in at $3.8 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2017 was $3.8 million (changed 0.0% YoY), and the FY2016 annual result was $3.8 million, changed 0.0% from the prior year.
  • Treasury Shares steadied at $3.8 million in Q3 2017 per SLS's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $2.3 million in Q1 2026 and troughed at $255000.0 in Q4 2022.
  • A 5-year average of $799411.8 and a median of $472000.0 in 2024 frame the typical range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 0.0% in 2013 and fell as far as 0.0% in 2013.
  • A 5-year view of Treasury Shares shows it stood at $3.8 million in 2013, then changed by 0.0% to $3.8 million in 2014, then changed by 0.0% to $3.8 million in 2015, then changed by 0.0% to $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017.
  • Business Quant data shows SLS's Treasury Shares at $3.8 million in Q3 2017, $3.8 million in Q2 2017, and $3.8 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 700,000.00
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - 2.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.26 Mn
Mar 31, 2026 2.26 Mn
Dec 31, 2025 897,000.00
Dec 31, 2025 897,000.00
Sep 30, 2025 1.71 Mn
Sep 30, 2025 1.71 Mn
Jun 30, 2025 1.71 Mn
Jun 30, 2025 1.71 Mn
Mar 31, 2025 1.71 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 472,000.00
Dec 31, 2024 472,000.00
Sep 30, 2024 644,000.00
Sep 30, 2024 644,000.00
Jun 30, 2024 644,000.00
Jun 30, 2024 644,000.00
Mar 31, 2024 738,000.00
Mar 31, 2024 738,000.00
Dec 31, 2023 338,000.00
Dec 31, 2023 338,000.00